Diamond Bio - Life Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 06-12-2024
- Paid Up Capital ₹ 5.00 M
as on 06-12-2024
- Company Age 35 Year, 2 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 15.90 Cr
as on 06-12-2024
- Satisfied Charges ₹ 0.50 M
as on 06-12-2024
About Diamond Bio - Life
The Corporate was formerly known as Diamond Transformers P Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹15.90 Cr. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Jayanti Oza and Rupal Oza serve as directors at the Company.
- CIN/LLPIN
U31200MH1989PTC053751
- Company No.
053751
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 1989
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Diamond Bio - Life Private Limited offer?
Diamond Bio - Life Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Diclofenac, Diclofenac Sodium Injection.
Who are the key members and board of directors at Diamond Bio - Life?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayanti Oza  | Director | 04-Oct-1989 | Current |
| Rupal Oza | Director | 04-Oct-1989 | Current |
Financial Performance and Corporate Structure Insights of Diamond Bio - Life.
Enhance accessibility to Diamond Bio - Life's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Diamond Bio - Life?
Unlock access to Diamond Bio - Life's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Asrec (India) Limited Creation Date: 24 Mar 2009 | ₹1.80 Cr | Open |
Asrec (India) Limited Creation Date: 24 Mar 2009 | ₹6.15 Cr | Open |
Asrec (India) Limited Creation Date: 23 Mar 2009 | ₹7.95 Cr | Open |
How Many Employees Work at Diamond Bio - Life?
Unlock and access historical data on people associated with Diamond Bio - Life, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diamond Bio - Life, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diamond Bio - Life's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
